Pharmaceutical Intelligence

Every business operating in the pharma industry is faced with decisions that cost millions or even billions of dollars and the balance between risk and return is a critical one. Research and development is a hugely expensive and time consuming process so understanding which areas to invest in is critical to big pharma and small biotechs alike.

Biotech companies focused on drug discovery are the lifeblood of the industry but the costs and resources associated with developing new treatments require heavy investment from both private and public equity. To achieve this investment and secure the future of their pharmaceutical business, it’s critical to have accurate, timely data that will demonstrate the likelihood of success in any given therapeutic area

We combine deep industry knowledge and analytical expertise to give you a solid foundation for your strategic decisions.

Over twenty years, we have developed methods to smooth out outlying pharmaceutical data points and differing methodologies, transparently and consistently. So you’ll always be able to understand the data you’re working with and what it means for your business.

To add to our market-leading pharma intelligence delivered through consensus forecasts, break through the limitations of conventional forecasting with comprehensive and granular coverage of assets, unrivalled accuracy and multi-dimensional analytics powered by machine learning.

Machine learning takes into account clinical trial and market intelligence data, R&D costs and development timelines to deliver highly accurate predictions of drug development success, both from commercial and regulatory perspectives.